Detalles de la búsqueda
1.
Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
BMC Cancer;
24(1): 192, 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347461
2.
Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer?
Curr Treat Options Oncol;
25(4): 496-509, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372852
3.
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer.
Curr Issues Mol Biol;
44(11): 5756-5767, 2022 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36421674
4.
Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study.
Clin Transl Oncol;
2024 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615292
5.
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3ß Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.
Clin Cancer Res;
30(3): 522-531, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37982822
6.
Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era.
J Immunother Precis Oncol;
6(3): 150-157, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37637236
7.
SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer.
Cancers (Basel);
15(19)2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835502
8.
Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches.
Cancers (Basel);
15(22)2023 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001644
9.
A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma.
Vaccines (Basel);
11(8)2023 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37631925
10.
Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis.
Cancers (Basel);
15(15)2023 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568570
11.
Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers.
JCO Precis Oncol;
7: e2300088, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37677121
12.
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival.
Cancers (Basel);
15(20)2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894419
13.
Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells.
J Hematol Oncol;
15(1): 134, 2022 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36104795
14.
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3ß inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
Neurooncol Adv;
4(1): vdac012, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35402914
15.
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3ß) inhibitor, in refractory adult T-Cell leukemia/lymphoma.
Cancer Biol Ther;
23(1): 417-423, 2022 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815408
16.
GSK-3ß in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties.
Biology (Basel);
10(7)2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34356465
17.
Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma.
Am J Clin Dermatol;
19(5): 657-670, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29961183
18.
Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease.
Cancer Manag Res;
7: 47-50, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25632239
19.
Combined modality therapy in pancreatic adenocarcinoma: review and updates on a controversial issue.
Curr Pharm Des;
20(42): 6697-701, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25341941
20.
Long-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis.
Asian Pac J Cancer Prev;
15(8): 3435-41, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24870735